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Although it has been suggested that taurine is the main endogenous neurotransmitter
acting on glycine receptors, the implications of glycine receptor-mediated taurine actions
on immature neocortical networks have not been addressed yet. To investigate the
influence of taurine on the excitability of neuronal networks in the immature neocortex,
we performed whole-cell patch-clamp recordings from visually identified pyramidal
neurons and interneurons in coronal slices from C57Bl/6 and GAD67-green fluorescent
protein (GFP) transgenic mice (postnatal days 2–4). In 46% of the pyramidal neurons
bath-application of taurine at concentrations ≥300 µM significantly enhanced the
frequency of postsynaptic currents (PSCs) by 744.3 ± 93.8% (n = 120 cells). This
taurine-induced increase of PSC frequency was abolished by 0.2 µM tetrodotoxin (TTX),
1 µM strychnine or 3 µM gabazine, but was unaffected by the glutamatergic antagonists
6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and (±) R(-)-3-(2-carboxypiperazine-4-yl)-
propyl-1-phosphonic acid (CPP), suggesting that taurine specifically activates GABAergic
network activity projecting to pyramidal neurons. Cell-attached recordings revealed that
taurine enhanced the frequency of action potentials (APs) in pyramidal neurons, indicating
an excitatory action of the GABAergic PSCs. In order to identify the presynaptic targets of
taurine we demonstrate that bath application of taurine induced in GAD67-GFP labeled
interneurons an inward current that is mainly mediated by glycine receptors and can
generate APs in these cells. We conclude from these results that taurine can enhance
network excitability in the immature neocortex by selectively activating GABAergic
interneurons via interactions with glycine receptors.
Keywords: GABAA receptor, glycine receptor, development, neocortex, GABAergic excitation, interneuron, cortical
plate, subplate
INTRODUCTION
A variety of studies reported that ionotropic receptors for γ-
amino butyric acid (GABA) are functionally expressed during
pre- and early post-natal development (e.g., Laurie et al., 1992;
Fritschy et al., 1994; Van Eden et al., 1995) and that such GABAA
receptors mediate depolarizing responses in immature hippocam-
pal (Ben-Ari et al., 1989; Rivera et al., 1999; Sipila et al., 2005)
and neocortical neurons (Owens et al., 1996; Achilles et al., 2007;
Ben-Ari et al., 2012). GABAA receptors are critically involved in
several developmental steps (reviewed in Wang and Kriegstein,
2009), like regulating neuronal proliferation (LoTurco et al., 1995;
Haydar et al., 2000), migration (Behar et al., 2000; Cuzon et al.,
2006; Heck et al., 2007), neurite growth (Sernagor et al., 2010)
and synaptic integration (Wang and Kriegstein, 2008). Most of
these effects are mediated by tonic GABAergic activation of non-
synaptic receptors (reviewed in Kilb et al., 2013). In addition
to these non-synaptic processes, GABAergic synaptic inputs had
been demonstrated in various neuronal populations of the neo-
cortex during pre- and early post-natal stages (Owens et al.,
1999; Kilb and Luhmann, 2001; Hanganu et al., 2002; Radnikow
et al., 2002; Rheims et al., 2008). It has been suggested that
GABAergic depolarizations provide the excitatory drive necessary
for early network activity (Sipila et al., 2005; Ben-Ari, 2006, 2012),
although in the neocortex early synchronous network oscillations
are mainly independent of GABAergic signaling (Garaschuk et al.,
2000; Allene et al., 2008). Such early network activity probably
also plays an important role in the functional maturation of neo-
cortical circuits (Ben-Ari, 2002; Spitzer, 2006; Hanganu-Opatz,
2010; Kilb et al., 2011).
On the other hand, no major anatomically disturbances of
the perinatal neocortex and hippocampus were observed in the
absence of GABA (Ji et al., 1999) or synaptic GABA release
(Wojcik et al., 2006), suggesting that other intrinsic GABAergic
agonists may act on GABAA receptors during early development.
Taurine, a partial agonist of GABAA (Albrecht and Schousboe,
2005) and glycine receptors (Flint et al., 1998), is one possible
candidate. Taurine can be released by a variety of stimuli in
the adult nervous system (Saransaari and Oja, 1998; Oja and
Saransaari, 2000). A non-vesicular release of taurine can be
induced by electrical stimulation and in the presence of a hypoos-
molar solution in the immature neocortex (Flint et al., 1998; Kilb
et al., 2008). Taurine has been shown to be directly involved in
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the development of the central nervous system (CNS; Palackal
et al., 1986; Sturman et al., 1994; Maar et al., 1995; Behar et al.,
2001) and influences the shift from depolarizing to hyperpolar-
izing GABAergic responses (Inoue et al., 2012). In accordance
with the depolarizing effect of GABA, taurine also depolarizes
different neuronal populations of the immature neocortex via an
activation of GABAA and glycine receptors (Ito and Cherubini,
1991; Flint et al., 1998; Kilb et al., 2002, 2008). However, the
effect of such depolarizing taurine responses on the network
activity in the immature neocortex has to our knowledge not been
investigated yet.
To analyze the influence of taurine on network activity in
the immature neocortex we investigated the effect of taurine
application on the spontaneous postsynaptic currents (PSCs)
recorded in pyramidal neurons of the mouse neocortex at postna-
tal days (P) 2–4. These experiments revealed that taurine induced
a massive increase in the frequency of GABAergic PSCs, which
is suppressed by the glycinergic agonist strychnine and mediated
an excitatory response in these cells. Recordings from genetically
labeled GABAergic interneurons showed that taurine induced
an inward current, mainly mediated by glycine receptors, and
thereby generate action potentials (APs) in these cells. These
findings suggest that in the early postnatal neocortex taurine
can activate GABAergic networks via an interaction with glycine
receptors on GABAergic interneurons and may thereby influence
the maturation of neocortical network.
MATERIALS AND METHODS
PREPARATION OF THE CORTICAL SLICES
Animal handling was performed in accordance with EU directive
86/609/EEC for the use of animals in research and approved
by the local ethical committee (Landesuntersuchungsanstalt RLP,
Koblenz, Germany). All efforts were made to minimize the
number of animals and their suffering. For electrophysiological
experiments coronal slices of the neocortex were prepared from
pups of C57Bl/6 or GAD67-GFP transgenic mice (Tamamaki
et al., 2003) at P2–P4. Mice were deeply anesthetized by enflu-
rane (Abbot, Wiesbaden, Germany). After opening of the skull,
the brain was quickly removed and placed in ice-cold artificial
cerebrospinal fluid (ACSF; composition given below). Whole-
brain 400 µM thick coronal slices were cut on a vibratome (HR2,
Sigmann Elektronik, Hüffenhardt, Germany) and cut along the
midline to separate the two hemispheres. Only coronal slices
that according to an atlas of the developing rat brain (Paxinos
and Franklin, 2001) included the primary somatosensory cortex
were transferred to an incubation-storage chamber. Slices were
allowed to recover for at least 1 h before recording. For some
experiments a reduced slice preparation was required. For that
coronal slices with a thickness of 400 µM were placed under
a binocular and trimmed with a scalpel blade to a width of
approximately 2–3 mm. In some of these slices the subplate (SP)
and white matter were identified by eye and the SP was removed
with a scalpel blade.
ELECTROPHYSIOLOGICAL SETUP
The videomicroscopic setup consisted of an upright micro-
scope (BW51WI, Olympus) with infrared differential interference
contrast (IR-DIC) optics (Dodt and Zieglgänsberger, 1990), and
a CCD-camera (C5405, Hamamatsu, Japan). The video image
was contrast enhanced by a video processor (C 2400, Hama-
matsu) and visualized on a video-monitor. For whole-cell and
cell-attached patch-clamp experiments pipettes were made from
borosilicate tubing (2.0 mm outside diameter, 1.16 mm inside
diameter; Science Products, Hofheim, Germany) using a vertical
puller (PP-83, Narishige, Tokyo, Japan) and filled with pipette
solution (see below). The patch pipettes were connected to
the headstage of a discontinuous voltage-clamp/current-clamp
amplifier (SEC05L, NPI, Tamm, Germany). Signals were ampli-
fied, low-pass filtered at 3 kHz, visualized on an oscilloscope
(HM507, Hameg Instruments), digitized on-line by an AD/DA-
board (ITC-18, Heka, Lamprecht, Germany), recorded and pro-
cessed with the software WINTIDA 5.0 (Heka), and stored on a
personal computer. The slices were transferred into a submerged
recording chamber, mounted on the fixed stage of the micro-
scope and were superfused with ACSF at a rate of 1–2 ml/min.
All experiments were performed at 30 ± 1◦C maintained by a
peltier-element based temperature controller (Luigs & Neumann,
Ratingen, Germany).
ELECTROPHYSIOLOGICAL PROCEDURES AND ANALYSIS
Resting membrane potential (RMP) was measured directly after
establishing whole-cell configuration. All potentials were cor-
rected for a liquid junction potential of 9.1 mV. Input resis-
tance and capacitance were determined from amplitude and
rise kinetics of voltage deflections to 300 ms hyperpolarizing
current pulses. AP amplitude was defined as voltage difference
between firing threshold and peak depolarization and AP width
was measured at half-maximal amplitude. PSCs were detected
and analyzed in continuous voltage-clamp recordings lasting at
least 180 s at a holding potential (Eh) of −69.1 mV (except
where noted), using the program MiniAnalysis 4.3.3 (Synaptosoft,
Leonia, NJ, USA). Frequencies of APs and PSCs were determined
during at least 3 min of the recording immediately before ago-
nist application for control conditions, and during the complete
period of agonist application for the agonist condition. Holding
currents were determined during a ca. 1 min interval directly
before agonist application for control conditions and during a
similar interval in the maximal phase of the agonist response.
Cells were considered as responsive to agonists, if the frequency
of PSCs in the presence of agonists (calculated from inter-event
intervals) was 4x larger than the standard deviation of the fre-
quency during the control interval. For taurine concentrations
≤100 µM cells were only considered as non-responsive, if the
cells showed a taurine-induced increase in PSC frequency at
higher taurine doses. The reversal potential (ERev) was calculated
from the Goldman equation using Cl− concentrations, estimated
HCO−3 concentrations and a relative bicarbonate permeability
of 0.2 (Bormann et al., 1987). Cell-attached experiments were
performed either under current-clamp conditions at a holding-
potential of −60 mV or under bridge-mode condition with no
holding-current applied. Cells were considered as responsive to
taurine application if AP frequency increases by more than 50%
and more than five APs occur. In most experiments agonists
and antagonists were applied via the bathing-solution. For some
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pharmacological experiments taurine, glycine, or isoguvacine was
applied focally to the soma of the investigated cells via a patch
pipette for 2–100 ms with a pressure of 0.4 bar using a pressure
application system (LHDA0533115H, Lee, Westbrook, CT, USA).
SOLUTIONS AND SUBSTANCES
ACSF contained (in mM) 124 NaCl, 26 NaHCO3, 1.25 NaH2PO5,
1.8 MgCl2, 1.6 CaCl2, 3 KCl, 20 glucose (equilibrated with 95%
O2/5% CO2), osmolarity 333 mOsm (determined by a freezing
point osmometer, Knauer, Berlin, Germany). Standard pipette
solution for whole-cell recordings contained (in mM) 44 KCl,
80 K-gluconate, 1 CaCl2, 2 MgCl2, 11 ethylene glycol tetraacetic
acid (EGTA), 10 4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid (HEPES), 2 Na2-ATP, 0.5 Na-GTP, pH adjusted to 7.4 with
KOH and osmolarity to 306 mOsm with sucrose. For low-Cl−
pipette solution, the KCl concentration was reduced to 2 mM
and the K-Gluconate concentration raised to 124 mM. For cell-
attached recordings the pipette solution contained (in mM) 126
K-Gluconate, 4 KCl, 1 CaCl2, 2 MgCl2, 11 EGTA, 10 HEPES,
2 Na2-ATP, 0.5 Na-GTP, pH adjusted to 7.4 with KOH and
osmolarity to 306 mOsm with sucrose.
Taurine was dissolved directly in ACSF, gabazine (SR-95531),
6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) or strychnine
were used from a stock solution in dimethylsulfoxide (DMSO),
tetrodotoxin (TTX) from a stock solution in citrate buffer
and glycine or (±) R(-)-3-(2-carboxypiperazine-4-yl)-propyl-1-
phosphonic acid (CPP) from an aqueous stock solution. TTX was
purchased from RBI (Natic, MA), glycine and taurine from Tocris
(Ballwin, MO), and all other substances from Sigma. The final
DMSO concentration never exceeded 0.5%.
STAINING PROCEDURES
In all whole-cell experiments 0.5 % biocytin (Sigma, Taufkirchen,
Germany) was added to the pipette solutions to label the recorded
neurons. Slices were fixed in a 4% parafolmaldehyde solution
immediately after recording for more than 24 h. After washing
in phosphate buffer, slices were incubated in blocking solution
(4% normal goat and 3% normal bovine serum, 0.5% Triton,
0.05% sodium azide in phosphate buffered saline (PBS)) for 2 h
at RT. Subsequently, biocytin-labeled neurons were stained with
Cy-3 conjugated streptavidin (Dianova, Hamburg, Germany) as
described in detail before (Achilles et al., 2007). Since the green
fluorescent protein (GFP) fluorescence was not stable during
the biocytin-streptavidin reaction, these slices were subsequently
counterstained for GFP by incubating the slices with a GFP
antibody raised in rabbit (1:500, Invitrogen, Karlsruhe, Germany)
overnight at RT followed by a donkey anti-rabbit IgG secondary
antibody conjugated with Dylight 488 (1:100; Dianova). Slices
were embedded in fluoromount (Sigma). Immunofluorescence
was investigated with a Nipkow spinning disk confocal system
(Visitech, Sunderland, UK) attached to a conventional fluores-
cence microscope (Olympus BX51 WI) equipped with water
immersion objectives and a cooled CCD-camera (CoolSnap HQ,
Roper Scientific) controlled by MetaMorph software (Universal
Imaging, West Chester, USA). Green and red fluorescence was
excited with the 488 nm and the 568 nm lines of a Kr/Ar laser
(Laser Physics, Malpas, UK).
STATISTICS
All values are expressed as mean ± standard error of the mean
(SEM). For statistical analysis Student t-test, Mann-Whitney-
U-test, ANOVA tests and Fishers Exact test were used (Systat
11, Systat Inc., Point Richmond, CA). Results were designated
significant at a level of p< 0.05.
RESULTS
BASIC PROPERTIES OF THE INVESTIGATED CELLS
In total 530 pyramidal neurons from P2–P4 mice pups identified
by their location in the neocortex and their pyramidal like appear-
ance in IR-DIC image were investigated using whole-cell patch-
clamp recordings (Figure 1A). These neurons had an average
RMP of −68.9 ± 0.4 mV (n = 530), an input resistance of 1.7
± 0.04 G and an input capacity of 72.8 ± 2.5 pF. In 96% of
all 450 neurons investigated for this aspect APs with an average
amplitude of 54.8± 0.4 mV (n = 428) and duration of 4.4± 0.08
ms could be evoked upon a depolarization that crosses the AP-
threshold of−41.7± 0.3 mV (Figure 1B).
In addition, 38 GFP+ GABAergic interneurons were recorded
under whole-cell conditions (Figure 1C). These GABAergic
interneurons had an average RMP of−64.6± 1.8 mV (n = 38), an
input resistance of 3.3 ± 0.3 G and an input capacity of 37.2 ±
5.0 pF. Injection of a depolarizing current evoked in these neurons
APs with an amplitude of 37± 1.8 mV (n = 35), a duration of 2.9
± 0.3 ms and an AP-threshold of −45.1 ± 0.9 mV (Figure 1D).
Upon persistent injection of depolarizing currents these cell could
discharge with a maximal frequency of 44.2 ± 2.8 Hz (n = 30),
with a considerable heterogeneity.
FOCAL TAURINERGIC RESPONSES
To investigate the pharmacology of postsynaptic taurine
responses, we first applied 5 mM taurine directly to the soma of
the recorded pyramidal cell. Focal taurine application (2–5 ms)
induced in pyramidal neurons an inward current of −260.4 ±
31.9 pA (n = 12), which reversed at −22.3 ± 1.5 mV (n = 10,
Figure 2A), in accordance with the Cl− concentration of 50 mM
in the pipette solution. Bath application of 1 µM strychnine
significantly (p < 0.001) reduced the amplitude of taurine-
induced currents by 80 ± 5.2% (n = 7, Figures 2B, D). Bath
application of 3 µM gabazine reduced the amplitude of taurine-
induced currents by 22 ± 2.5% (n = 8, Figures 2C, D), and the
combined application of 1 µM strychnine and 3 µM gabazine
completely blocked taurine induced currents (n = 6, Figure 2B).
Interestingly, in GABAergic interneurons the taurine-induced
inward current of 154.8± 22 pA (n = 10) was completely blocked
by 1 µM strychnine (n = 9), while 3 µM gabazine (n = 8) had no
effect (99.3± 6.6%; Figure 2E). In summary, these results suggest
that the inward currents induced by high taurine concentrations
were in pyramidal cells carried by both GABAA and glycine
receptors, with the GABAA receptors mediating approximately
20% and glycine receptors approximately 80% of the responses,
while in interneurons this current was exclusively mediated by
glycine receptors.
As it had been shown that the pharmacological properties
of glycine and GABAA receptors change during development
(Aguayo et al., 2004; Carlson and Yeh, 2011), we next performed
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FIGURE 1 | Identification and basic electrophysiological properties of
neocortical pyramidal neurons and GABAergic interneurons. (A) Typical
interference contrast image of a pyramidal neuron (arrowhead in left image)
and the same neuron after biocytin-labeling and subsequent histochemical
processing. (B) Voltage-traces of the neuron shown in A upon injection of
de- and hyperpolarizing current pulses. (C) Confocal fluorescence images
displaying GFP-positive interneurons (left), a biocytin-labeled recorded
neuron (middle) and the merged picture (right). (D) Representative voltage
traces of a GABAergic interneuron. Note the high firing frequency in this
recording.
control experiments to analyze the efficacy of strychnine and
gabazine in immature pyramidal cells. In these experiments focal
application of 100 µM glycine induced an inward current of
180.2 ± 42.5 pA (n = 9) that was completely blocked by 1 µM
strychnine (n = 6), while 3 µM gabazine (n = 7) had no effect
(103± 7.4%, n = 7, Figure 2F). Focal application of the GABAer-
gic agonist isoguvacine (100 µM) induced an inward current
of 382.3 ± 37.9 pA (n = 7) that was completely blocked by
3 µM gabazine (n = 6), while 1 µM strychnine had no effect
(99 ± 1.8%, n = 4, Figure 2G). Similar results were obtained
in interneurons. Focal application of 100 µM glycine induced
in GABAergic interneurons a current of 91.4 ± 21.2 pA (n =
7) that was completely blocked by 1 µM strychnine (n = 7),
whereas 3 µM gabazine had no effect 106.2 ± 5.3% (Figure 2H).
Focal application of 100 µM isoguvacine induced in GABAergic
interneurons a current of 131.6 ± 40.7 pA (n = 7) that was
completely blocked by 3 µM gabazine (n = 7), whereas 1 µM
strychnine had no effect (96.3 ± 3.8%; Figure 2I). These experi-
ments demonstrate that 1 µM strychnine and 3 µM gabazine can
be used as specific antagonists for glycine and GABAA receptors,
respectively.
EFFECT OF TAURINE ON SPONTANEOUS SYNAPTIC CURRENTS
Bath application of taurine induced an inward current in pyrami-
dal neurons. While taurine concentration≤100 µM did not elicit
significant membrane currents (Figures 3A, C), inward currents
of 17.3 ± 0.8 pA (n = 258), 46.9 ± 7.4 (n = 20) and 52 ±
8.8 pA (n = 15) were induced by bath application of 300 µM,
1 mM and 3 mM taurine, respectively (Figures 3B, C). The
taurine-induced current showed a pronounced desensitization
by 27.5 ± 3.8% and 31.4 ± 9% in 1 mM and 3 mM taurine,
respectively, while no obvious desensitization occurred at lower
taurine concentrations.
In addition to this inward current, bath application of taurine
increased the frequency of PSCs in a considerable fraction of
pyramidal neurons. While no significant effect was observed at
taurine concentration ≤100 µM (Figures 3A, C), in 46.8% (133
out of 275 cells) of all investigated neurons bath application of
300 µM taurine induced an increase in the frequency of PSCs
(Figure 3B). In 125 of these cells a significant (>4x SD of control)
increase of PSC frequency by 815 ± 86% from 0.16 ± 0.02 Hz
(n = 138) to 0.59 ± 0.05 Hz (n = 125, Figure 3D) was induced.
In the eight additional neurons that showed PSCs during taurine
application, PSCs were absent during the control interval. The
majority (91.5%) of the remaining 142 neurons did no show
PSCs neither before nor in the presence of 300 µM taurine,
while in 12 neurons no significant increase in PSC frequency
(between 89 and 229% of control) was observed in the presence of
300 µM taurine. The frequency of taurine-induced PSCs showed
no significant correlation (r2 = 0.17) with the PSC frequency
during the control interval. In addition, the amplitude of PSCs
increased from 19.3 ± 1 pA (n = 137) to 24.6 ± 1.3 pA (n =
145) in the presence of 300 µM taurine. Furthermore, increasing
the taurine concentration to 1 mM or 3 mM induced comparable
effects on PSCs. Bath application of 1 mM taurine increased the
frequency of PSCs in 10 out of 21 investigated neurons by 694 ±
210%, while 3 mM taurine increased the frequency in 6 out of
15 neurons and 518 ± 198% (n = 7, Figure 3D). Neither the
amplitude nor the frequency was significantly different from the
effects of 300 µM taurine, indicating that 300 µM taurine was
sufficient to provoke a maximal effect on PSCs. Therefore we
performed all subsequent experiments with 300 µM taurine. To
test if taurine responses are stable during repetitive applications
we applied 300 µM taurine for three times to the same cell.
These experiments revealed no significant differences in taurine-
induced inward currents (Figure 3E) as well as in amplitude
and frequency of taurine-induced PSCs between the first, second
and third taurine application (Figure 3F). In summary, these
results show that bath application of taurine at a concentration
≥300 µM increased the frequency of the PSCs in about half
of all pyramidal neurons, suggesting that activity of GABAergic
synapses was considerably increased by taurine.
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FIGURE 2 | Activation of GABAA and glycine receptors by focal
application of 5 mM taurine in pyramidal neurons and GABAergic
interneurons. (A) Current-voltage (I–V) plot of the inward current after focal
application of 5 mM taurine at different voltages. Note the linear I–V relation
and that the current reversed close to the estimated reversal potential.
(B) Inward currents elicited by a 5 ms application of 5 mM taurine (Tau) are
reduced in the presence of 1 µM strychnine (Stry). After a partially washout
of strychnine, combined application of 3 µM gabazine (GBZ) and 1 µM
strychnine completely suppressed the taurine-induced current. (C) Inward
currents elicited by 5 mM taurine are slightly reduced in the presence of
3 µM GBZ. (D) Statistical analysis of these experiments. Bars represent
mean ± SEM of maximal inward current amplitudes. (E) In GABAergic
interneurons, focal application of 5 mM taurine induced an inward current that
is unaffected by 3 µM GBZ and completely blocked in the presence of 1 µM
strychnine. (F) In pyramidal neurons focal application of 100 µM glycine
induced an inward current that was unaffected in the presence of 3 µM GBZ
and completely blocked in the presence of strychnine. (G) In pyramidal
neurons focal application of 100 µM isoguvacine induced an inward current
that was unaffected by strychnine and completely blocked in the presence of
GBZ. (H) In GABAergic interneurons focal application of 100 µM glycine
induced an inward current that was unaffected by GBZ, but completely
blocked in the presence of strychnine. (I) In GABAergic interneurons focal
application of 100 µM isoguvacine induced an inward current that was
completely blocked by GBZ, but unaffected in the presence of strychnine.
PHARMACOLOGY OF TAURINE-INDUCED RESPONSES IN PYRAMIDAL
NEURONS
Next we analyzed the pharmacological properties of the
PSCs evoked by the bath application of 300 µM taurine.
Bath-application of TTX inhibited the taurine-induced PSCs
(Figure 4A). In the presence of 0.2–1 µM TTX bath application
of 300 µM taurine fails to increase the frequency (101.6 ±
14.3%, n = 6) and amplitude (97.4 ± 5%) of PSCs. In
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FIGURE 3 | The effect of bath-applied taurine on pyramidal neurons.
(A) Whole-cell voltage-clamp recording from a pyramidal neuron. Bath
application of 30 µM taurine did not affect the holding current or the
frequency of the PSCs. (B) Bath application of 300 µM taurine induced an
inward current and a massive increase in the frequency of PSCs. (C)
Statistical analysis of inward current amplitudes induced by different taurine
concentration. (D) Statistical analysis of relative PSC frequency (normalized
to control intervals) in the presence of different taurine concentrations.
Note that the effect of taurine on PSC frequency displays a clear threshold
behavior. (E, F) Neither the amplitude of the inward current (E), nor
amplitude (black bars) and frequency (gray bars) of taurine-induced PSCs
differ significantly in three consecutive applications. Bars represent mean ±
SEM, number of experiments is given in the bars.
three additional TTX-treated slices that did not show sponta-
neous PSCs under control conditions, 300 µM taurine failed to
evoke PSCs. The taurine-induced inward current was, however,
not significantly affected under this condition (137 ± 25.1%,
n = 9). These observations suggest that the taurine-induced
increase in PSC frequency requires the activation of presynaptic
networks.
FIGURE 4 | Pharmacology of taurine responses. (A) Typical current
registration illustrating that taurine-induced increase in the PSC frequency
was suppressed in the presence of 1 µM TTX. (B) Typical current
registration illustrating that the taurine-induced increase in PSCs frequency
was not affected in the presence of 10 µM CNQX 6-cyano-7-
nitroquinoxaline-2,3-dione (CNQX) + 20 µM (±)
R(-)-3-(2-carboxypiperazine-4-yl)-propyl-1-phosphonic acid (CPP). (C)
Statistical analysis of the effect of glutamatergic antagonists on relative
frequency and amplitude of taurine-induced PSCs. Bars represent mean ±
SEM, numbers of experiments are given in the bars.
Inhibition of ionotropic glutamate receptors by bath appli-
cation of 10 µM CNQX or 20 µM CPP had no significant
effect on the taurine-induced PSCs. In the presence of both
glutamate antagonists neither amplitude (27.13 ± 3 vs. 31.6 ±
6.3 pA) nor the frequency (0.55 ± 0.09 vs. 0.55 ± 0.11 Hz)
of taurine-induced PSCs was significantly (p = 0.5 and p = 1,
respectively, n = 9) different from the control application in ACSF
(Figures 4B, C). The taurine-induced inward current was also
unaffected under this condition (15.9 ± 2.1 vs. 17.7 ± 4.3 pA,
n = 9). Similar results were obtained if these glutamate receptor
antagonists were applied alone (Figure 4C). These results suggest
that glutamatergic synapses are not activated by bath application
of taurine. These experiments also revealed that the frequency
of spontaneous postsynaptic events (sPSCs) was not significantly
reduced in the presence of 10 µM CNQX and 20 µM CPP (128±
40%, n = 9).
On the other hand, bath application of the GABAA receptor
antagonist gabazine (3 µM) completely blocked sPSCs in 19
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FIGURE 5 | Effect of GABAA and glycine receptor antagonists on
taurine induced responses. (A) Typical current traces illustrating that 3 µM
gabazine (GBZ) abolished the taurine-induced increase in PSC frequency
and reduced the amplitude of the taurine-induced inward current. (B)
Typical current traces illustrating that 1 µM strychnine abolished the
taurine-induced increase in PSC frequency and reduced the amplitude of
the taurine-induced inward current.
out of 26 pyramidal cells investigated and massively reduced
the frequency of sPSCs to 0.023 ± 0.007 Hz in the remaining
seven neurons. This result indicates that the majority of sPSCs
is mediated by GABAA receptors. Bath application of 300 µM
taurine in the presence of 3 µM gabazine did not induce a
significant (p = 0.34) increase in frequency of PSCs (0.06 ±
0.02 Hz, n = 5, Figure 5A), suggesting that GABAA receptors
are required for this taurine effect. The taurine-induced inward
current was significantly (p < 0.001) reduced by 79.6 ± 8.3%
(n = 8) from 21 ± 2.6 to 5.6 ± 2.5 pA in the presence of
gabazine.
Bath application of the glycine receptor antagonist strychnine
(0.3–1 µM) had no significant effect on frequency (107 ± 15%,
n = 12) and amplitude (92 ± 11%) of sPSCs, supporting pre-
vious reports that glycine receptors are not directly involved in
synaptic transmission in the developing neocortex (Flint et al.,
1998; Okabe et al., 2004; Kilb et al., 2008). However, in the
presence of 0.3–1 µM strychnine the taurine-induced increase
in PSC frequency was completely suppressed (Figure 5B). Under
this condition bath application of taurine had no effect on the
frequency (0.11± 0.01 vs. 0.11± 0.02 Hz, n = 12) and amplitude
(13.84 ± 0.9 vs. 16.3 ± 2.4 pA, n = 12) of PSCs. In addition,
the taurine-induced inward current was significantly (p < 0.001)
reduced by 47.7± 8.3% (n = 12) from 22.2± 2.8 to 9.7± 1.1 pA.
In the presence of both, 1 µM strychnine and 3 µM gabazine
the taurine-induced inward current was massively reduced by
95.5 ± 1.2% to 1.1 ± 0.4 pA (n = 12). Under this condition bath
application of 300 µM taurine did also not increase the frequency
of PSCs (0.03 ± 0.004 vs. 0.03 ± 0.002, n = 8). In summary,
these results suggest that glycine receptors are essential for the
presynaptic taurine effect and also contribute to the postsynaptic
taurinergic currents.
Since the previous results indicate that taurine acting ton-
ically on presynaptic glycine receptors enhance the frequency
of putative GABAergic PSCs, we next directly stimulated presy-
naptic GABAA and glycine receptors. These experiments were
performed in the presence of 10 µM CNQX and 20 µM CPP
to isolate GABAergic PSCs. Tonic activation of GABAA receptors
by bath application of 3 µM isoguvacine induced an inward
current of 19.8 ± 5.3 pA (n = 8). In addition, it increased the
frequency of PSCs by 566 ± 219% from 0.1 ± 0.04 to 0.24 ±
0.05 Hz (n = 8, Figure 6A). This result indicates that tonic
activation of presynaptic GABAA receptors is sufficient to enhance
GABAergic inputs to pyramidal cells. Bath application of 100 µM
glycine induced an inward current of 14.1 ± 4.8 pA (n = 6)
and increased the frequency of PSCs in 4 out of 6 investigated
pyramidal neurons by 1045 ± 831% (n = 4, Figure 6B) and
induced in the remaining two neurons, which did not showed
more than two PSCs in the control interval, a burst of PSCs. The
frequency of glycine-induced PSCs was 0.47 ± 0.19 Hz (n = 6).
To prove that these glycine-induced PSCs were indeed mediated
by GABAA receptors in the postsynaptic membrane, we next
applied 100 µM glycine in the continuous presence of 3 µM
gabazine, 10 µM CNQX and 20 µM CPP. Under this condition
spontaneous PSCs were absent and bath application of 100 µM
glycine did not induce PSCs (n = 6, Figure 6C), suggesting
that glycine application enhanced exclusively GABAergic PSCs.
In summary, these results indicate that activation of presynaptic
glycine but also GABAA receptors can increase the frequency of
GABAergic PSCs.
TAURINE INDUCED GABAergic POSTSYNAPTIC CURRENTS (PSCs)
THAT MEDIATE EXCITATORY RESPONSES
To strengthen our previous suggestion, that GABAA receptors
are underlying the taurine-induced PSCs in pyramidal neurons,
we next determined the reversal potential (ERev) of these PSCs.
For this purpose we performed voltage-clamp experiments using
a pipette-solution with a Cl− concentration of 8 mM, which
corresponds to an ERev of −62.5 mV. In these experiments the
cell was clamped exactly to ERev, which was determined experi-
mentally for each cell by a series of focal GABA pulses at different
holding potentials. These experiments revealed that the frequency
of sPSCs was reduced to from 0.042 ± 0.013 Hz (n = 7) to
0.021 ± 0.006 Hz (n = 7) if the membrane was clamped from
−85 mV to ERev, indicating that a substantial fraction of sPSCs is
mediated by ligand-gated Cl− channels. At this holding potential
bath application of 300 µM taurine had no significant (p = 0.35)
effect on the frequency of PSCs (77 ± 15%, n = 5, Figure 7A).
In contrast, under conditions when the holding potential was
negative (−85 mV) or positive (0 mV) to ERev bath application of
300 µM taurine significantly increased the frequency of PSCs to
454± 70% (n = 7) and 630± 149% (n = 11), respectively, indicat-
ing that taurine initiates PSCs that are mediated via ligand-gated
Cl− channels. Accordingly the taurine-induced PSCs reversed at
−56.7 mV, approximately at the estimated ERev (Figure 7B).
As many studies indicate that an activation of GABAA recep-
tors mediate depolarizing membrane responses in immature
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FIGURE 6 | Effect of bath applied isoguvacine and glycine on pyramidal
neurons in the presence of 10 µM CNQX and 20 µM CPP. (A) Typical
current recording demonstrating that bath application of 3 µM isoguvacine
induced an inward current and increased the PSC frequency. (B) Typical
trace illustrating that bath application of 100 µM glycine increased the
frequency of PSCs. (C) In the subsequent recording from the same neuron
as in B the PSCs induced by bath application of 100 µM glycine are
completely suppressed in the presence of 3 µM gabazine (GBZ).
neocortical neurons (Owens et al., 1996; Achilles et al., 2007;
Kolbaev et al., 2011b), we next investigated whether taurine-
induced membrane responses mediate excitatory actions under
physiological conditions. Therefore we performed cell-attached
recordings to investigate this effect under conditions in which the
intracellular Cl− concentration ([Cl−]i) remained undisturbed.
In 28 out of 35 investigated neurons spontaneous APs at a fre-
quency of 0.29 ± 0.9 Hz (n = 28) were observed, the remaining
eight cells showed less that three APs during the control interval.
Bath application of 300 µM taurine increased the AP frequency
in 20 (corresponding to 57%) of these neurons by more than
50% to 0.68 ± 0.16 Hz (Figure 7B). In 15 of the cells the AP
frequency was sufficiently high (>0.15 Hz, corresponding to >25
spikes per control interval) to estimate possible inhibitory action.
However, in only 3 of these 15 cells bath-application of taurine
reduced AP frequency. In order to unravel, whether the taurine-
induced increase in AP frequency was caused by GABAergic PSCs
or the depolarizing inward current, we next applied 300 µM
taurine in the presence of low gabazine concentrations, which
selectively inhibit phasic GABAergic currents (Stell and Mody,
2002; Kolbaev et al., 2012). Accordingly we were able to show
that bath application of 0.3 µM gabazine completely blocked the
taurine-induced increase in the frequency of GABAergic PSCs
(n = 7), while the tonic current was not significantly affected
(94.9 ± 16.3%, n = 7). Cell-attached recordings revealed that in
the presence of 0.3 µM gabazine bath application of 300 µM tau-
rine had no effect on AP frequency in 12 investigated cells, which
all revealed a taurine-induced increase in AP frequency under
control conditions (Figure 7C). These results strongly suggest
FIGURE 7 | Taurine induces Cl−-dependent, excitatory PSCs. (A) Current
traces recorded at a holding potential (Eh) of 0 mV (upper trace) and −85
mV (bottom trace). For the middle trace Eh was set exactly at the GABA
reversal potential (ERev), which was experimentally determined by focal
GABA pulses. There experiments were performed with a low Cl−
concentration in the pipette. Note that no taurine-induced increase in PSC
frequency is visible if Eh = ERev and that the PSCs reverse their direction at
this potential. Averaged PSCs are displayed at higher temporal resolution in
the right panel. (B) Typical trace of a cell-attached recording from a
pyramidal neuron. Bath application of 300 µM taurine induced APs. (C) In
the subsequent cell-attached recording from the same neuron as in B the
taurine-induced APs are completely suppressed in the presence of 0.3 µM
gabazine (GBZ).
that the taurine-induced PSCs are GABAergic and mediate an
excitatory action on pyramidal neurons.
EFFECT OF TAURINE ON GABAergic INTERNEURONS
Since the previous results demonstrated that taurine enhanced
the frequency of GABAergic PSCs, we next analyzed the effect
of taurine on GABAergic interneurons. Therefore we per-
formed whole-cell and cell-attached measurements on GABAer-
gic interneurons identified by GFP expression under the control
of GAD67 (Tamamaki et al., 2003). The whole-cell experiments
revealed that bath application of 300 µM taurine induced an
inward current of 10.6± 2.2 pA (n = 14). This inward current was
significantly attenuated by 49± 8% (n = 6, p = 0.0313) in the pres-
ence of 3 µM gabazine and by 70± 13% (n = 7, p = 0.0156) in the
presence of 1 µM strychnine (Figures 8A, B). In summary, these
results indicate that taurine mediates a tonic activation of glycine
receptors and to a lesser extent of GABAA receptors in these cells.
To analyze whether this taurine-induced inward current medi-
ates an excitatory effect under conditions with undisturbed
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FIGURE 8 | Effect of taurine on GABAergic interneurons. (A) Typical
current registration illustrating that bath application of 300 µM taurine
induced an inward current that was attenuated by 3 µM gabazine (GBZ). (B)
The taurine-induced inward currents revealed a stronger attenuation in the
presence of 1 µM strychnine. A and B were recorded in the continuous
presence of 0.5 µM TTX. (C) Typical cell-attached recording illustrating that
bath-application of 300 µM taurine increases the frequency of APs in
GABAergic interneurons.
[Cl−]i, we next performed cell-attached experiments. These
experiments revealed that bath application of 300 µM taurine
induced in 17 out of 30 investigated GABAergic interneurons
(corresponding to 56.7%) a significant (p < 0.001) increase in
AP frequency from 0.1 ± 0.02 to 1.1 ± 0.27 Hz (Figure 8C).
In summary, these results demonstrate that bath application of
300 µM taurine excites a considerably fraction of GABAergic
interneurons and that this activity is mediated mainly via glycine
receptors.
Finally, we investigated whether SP cells, which are com-
prised of a significant fraction of GABAergic neurons (Kanold
and Luhmann, 2010) and are activated by taurine (Kilb et al.,
2008), contribute to GABAergic taurine-induced PSCs. For this
purpose we used a reduced neocortical slice preparations either
containing or lacking the SP (Figure 9A). In both preparations
bath application of 300 µM taurine induced PSC activity. In
reduced slices that contained the SP, taurine increased the fre-
quency of PSCs by 531 ± 138% (n = 4) to 0.19 ± 0.02 Hz. A
comparable effect was observed in slices without SP, in which
the frequency of PSCs increased by 697 ± 170% (n = 6) to
0.26 ± 0.05 Hz (Figure 9B). The taurine-induced PSCs had
comparable amplitudes in both preparations (14.4 ± 1.9 vs. 18.8
± 1.8 pA). In summary, these results suggest that GABAergic SP
neurons do not contribute substantially to the taurine-induced
activity.
DISCUSSION
The main findings of this study can be summarized as follows:
(i) bath application of 300 µM taurine increased the frequency
FIGURE 9 | Taurine effect on pyramidal neurons in reduced slice
preparation. (A) Confocal images of biocytin-labeled neurons (green)
counter-stained with propidium jodide. Note the absence of the SP (white
arrowheads) in the right slice. (B) Typical current registration illustrating that
bath application of taurine increased the frequency of PSCs in a reduced
slice preparation without SP.
of PSCs in a considerable fraction of pyramidal neurons; (ii)
taurine, but also glycine and isoguvacine specifically increased
the frequency of GABAA receptor mediated PSCs; (iii) these
taurine-induced GABAergic PSCs mediated an excitatory effect;
(iv) taurine, acting mainly on glycine receptors, induced an
inward current and repetitive APs in GABAergic interneurons;
and (v) GABAergic SP neurons do not substantially contribute
to the taurine-induced activity. We conclude from these results
that taurine can enhance the activity of excitatory GABAergic
networks in the immature neocortex.
Passive and active membrane properties of the pyramidal
neurons from P2–P4 mice are in accordance with previous results
(Kriegstein et al., 1987; Luhmann et al., 2000; Picken Bahrey
and Moody, 2003; Okabe et al., 2004). The passive membrane
properties of the immature GABAergic interneuron as well as
the relatively low maximal firing frequency of these neurons are
in line with the developmental profile of immature interneurons
(Doischer et al., 2008; Okaty et al., 2009).
One major conclusion of our study is that taurine specifi-
cally increased the frequency of GABAergic PSCs. Several lines
of evidence support this hypothesis. First, the taurine-mediated
increase in PSC frequency was unaffected by glutamatergic
antagonists but completely suppressed by the GABAA recep-
tor antagonist gabazine. This finding may be explained by the
hypothesis that GABAA receptor activation on presynaptic cells
is required for the activation of the PSCs, but the observation that
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bath-application of glycine induced a similar gabazine-sensitive
increase in PSC frequency suggests that a taurine-mediated
glycine receptor activation is sufficient to induce these PSCs.
Second, the taurine-induced PSCs reversed around ECl, which
would, however, also match to a glycinergic neurotransmission.
But the observation that the glycine-induced increase in PSC fre-
quency was completely blocked by gabazine indicates that under
this condition only GABAergic PSCs were induced and suggests
that this is also the case for the taurine-induced PSCs. These
suggestions are supported by the observation that an adequate
glycinergic stimulation of presynaptic cells is required to provoke
taurine-induced PSCs. And finally, the observation that a specific
inhibition of synpatically GABAA receptors by low gabazine con-
centrations completely abolished the taurine-induced PSCs also
indicates that these PSCs were GABAergic. In summary, these
results strongly suggest that bath-application of taurine, but also
of glycine or isoguvacine, selectively activated GABAergic PSCs.
A variety of previous studies demonstrated that activation
of GABAA receptors mediate depolarizing membrane responses
in immature neurons, due to the high [Cl−]i in these cells
(Owens et al., 1996; Achilles et al., 2007; Ben-Ari et al., 2012).
Although such depolarizing responses do not necessarily enhance
the excitability of neurons (Jedlicka et al., 2011; Kolbaev et al.,
2011a), our observation that under cell-attached conditions tau-
rine can induce barrages of APs, which are abolished by a
specific inhibition of synaptic GABAergic currents with a low
dose of gabazine, convincingly demonstrate that these synaptic
GABAergic inputs mediate an excitation of immature pyramidal
neurons. This is in line with previous publications which reported
that in the immature neocortex GABAergic inputs from the zona
incerta can mediate excitatory responses in pyramidal neurons
(Dammerman et al., 2000) and that in immature GABAergic
interneurons and Cajal-Retzius cells GABAergic synaptic inputs
reliably trigger APs (Rheims et al., 2008; Cosgrove and Maccaferri,
2012).
Theoretically, the GABAergic PSCs can rely on an increased
spontaneous release probability of GABA vesicles or from an
excitation of presynaptic GABAergic interneurons (Hessler et al.,
1993; Kirmse and Kirischuk, 2006). However, as the taurine-
induced increase in PSCs frequency was absent in the presence
of TTX, these PSCs reflect an increased activity of GABAer-
gic interneurons rather than an increased release probability of
presynaptic neurotransmitter vesicles. Accordingly, we were able
to directly demonstrate that taurine induced an inward current
in GABAergic interneurons, which is in 56% of these neurons
sufficient to trigger APs. Interestingly the frequency of the APs
is higher than the frequency of the taurine-induced PSCs in
pyramidal neurons, suggesting a high failure rate and/or synaptic
fatigue in these GABAergic synapses, but probably also that only
few GABAergic interneurons make synaptic contacts to pyramidal
neurons at this age. The taurinergic inward current in GABAergic
interneurons was mimicked by bath application of glycine and
isoguvacine, indicating that both GABAA and glycine receptors
can potentially contribute to the taurine effect. The puzzling
observation that in interneurons strychnine abolished responses
to focal taurine application, while the tonic current mediated by
bath applied taurine was only reduced by 70%, may be caused
by distinct activation kinetics of glycine and GABA receptors
upon fast application and by a differential desensitization of both
receptors in the continuous presence of taurine. While GABAA
receptors had already been described in immature interneurons
(Gozlan and Ben-Ari, 2003), no evidences for glycine receptors
on cortical interneurons were reported so far. The observations
that strychnine completely blocked focal taurine responses and
suppressed bath-applied responses by 70%, while gabazine had a
lower efficiency, suggest that taurine exerts its effect on GABAer-
gic interneurons mainly via glycine receptors. Accordingly, the
taurine-induced GABAergic PSCs were abolished in the presence
of strychnine, illustrating that a taurinergic activation of only
GABAA receptors was insufficient to activate the presynaptic
GABAergic networks.
The subtype of the GABAergic interneurons that mediate
these excitatory synaptic inputs could not be defined in our
study. We can exclude that a GABAergic population of SP
neurons (Hanganu et al., 2002; Luhmann et al., 2009; Kanold
and Luhmann, 2010) is a major source of the taurine-induced
GABAergic PSCs, since we could demonstrate that even in a
reduced slice preparation, which lacks a SP, taurine increases
the frequency of PSCs. Although different subpopulations of
inhibitory interneurons can be identified in the mature neocor-
tex based on molecular, morphological and electrophysiological
parameters (Markram et al., 2004; Ascoli et al., 2008), the late
development of these markers (Doischer et al., 2008; Okaty et al.,
2009) does not allow a reliably identification of the prospec-
tive subtype of the recorded interneurons during early postnatal
development. The intriguing question, whether specific GABAer-
gic interneurons transiently integrate into immature excitatory
circuits thus remains elusive. Interestingly, GABAergic interneu-
rons receive reliably excitatory GABAergic inputs (Rheims et al.,
2008), while at least in the somatosensory neocortex no reliably
excitatory inputs from the thalamus were found in early postnatal
stages (Daw et al., 2007), suggesting that GABAergic interneurons
are integrated into transient, mainly GABAergic circuits that
mediate excitation rather than the feed-forward inhibition typical
for mature neocortical circuits. One intriguing observation of the
present study is that a taurine-induced increase in PSC frequency
was observed only in 46% of the investigated pyramidal neurons,
indicating that only a portion of the pyramidal neurons was
integrated into such functional GABAergic networks.
In the immature hippocampus early generated pioneer
GABAergic interneurons synchronize network activity transients
(Bonifazi et al., 2009; Picardo et al., 2011). Such spontaneous
early activity transients occur in most developing neuronal net-
works and are supposed to promote the formation of func-
tional networks (Spitzer, 2006; Hanganu-Opatz, 2010; Kilb et al.,
2011). In the neocortex, however, spontaneous network activity
or oscillatory events are mostly independent of GABAA receptors
(Garaschuk et al., 2000; Dupont et al., 2006; Allene et al., 2008),
although in ventral aspects of the neocortex a contribution of
GABAA receptors to spontaneous activity has been reported in
the first postnatal week (Conhaim et al., 2011). Therefore we
propose that this GABAergic excitatory network does not directly
contribute to large-scale activity transients, but controls the
excitability of specific, probably more local excitatory networks.
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Finally, it has to be considered that the taurine concentration
of 300 µM used in the present study most likely exceeds the
interstitial taurine levels that can be expected in the immature
neocortex. However, in rat and human fetal brains taurine is the
most abundant neurotransmitter (Das and Ray, 1997; Benitez-
Diaz et al., 2003). It has been suggested that taurine can be
released from immature neurons after electrical stimulation or by
hypoosmolar solution (Flint et al., 1998; Kilb et al., 2008) by non-
synaptic processes, e.g., by volume-sensitive organic osmolyte
channels or reversal of taurine transport (Ando et al., 2012).
Therefore we propose that such an activity-dependent non-
synaptic release of taurine can led to subtle changes in the
interstitial taurine concentrations, which in turn slightly increase
the excitability of immature networks and may thereby directly
influence the maturation of neocortical neuronal circuits.
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